A rabbit model of cerebral venous sinus thrombosis established by ferric chloride and thrombin injection

被引:6
|
作者
Wei, Ying [1 ]
Deng, Xin [1 ]
Sheng, Guan [1 ]
Guo, Xin-bin [1 ]
机构
[1] Zhengzhou Univ, Affiliated Hosp 1, Dept Neurointervent Radiol, 1 Jianshe Rd, Zhengzhou 450052, Henan, Peoples R China
基金
中国国家自然科学基金;
关键词
Cerebral venous sinus thrombosis; Superior sagittal sinus rabbit; Pathophysiological change; BLOOD-FLOW; VEIN-THROMBOSIS; RAT MODEL; OCCLUSION;
D O I
10.1016/j.neulet.2017.10.041
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Objective: Cerebral venous sinus thrombosis (CVST) is a life-threatening disease with high misdiagnosis and mortality rates due to its complex etiology and unknown pathophysiology. The present study aimed to establish an animal model suitable for assessing the pathophysiology of CVST and develop treatment methods. Methods: 40% ferric chloride (FeC13) was administered for 5 min followed by thrombin injection to induce superior sagittal sinus thrombosis (SSST). Digital subtraction angiography (DSA) was performed to ensure thrombosis and evaluate the recanalization rate 7 days post-CVST. Neurological evaluation, Evans blue injection, 2,3,5-Triphenyltetrazolium chloride (TTC), and hematoxylin-eosin (H & E) staining were used to assess thrombosis and the accompanying brain parenchyma. Results: SSST was detected in all model rabbits, with a thrombus recanalization rate of 10%. Brain infarction, hemorrhage, cell edema, and disruption of the blood-brain barrier (BBB) were also observed. Conclusion: The method of inducing cerebral venous sinus thrombosis by applying 40% FeC13 and injecting thrombin is feasible and efficient. This experimental model mimics the pathogenesis and pathophysiology of actual CVST.
引用
收藏
页码:205 / 212
页数:8
相关论文
共 50 条
  • [41] Anticoagulation for cerebral venous sinus thrombosis
    Coutinho, Jonathan
    de Bruijn, Sebastiaan F. T. M.
    deVeber, Gabrielle
    Stam, Jan
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (08):
  • [42] Cerebral Venous and Sinus Thrombosis in Women
    Coutinho, Jonathan M.
    Ferro, Jose M.
    Canhao, Patricia
    Barinagarrementeria, Fernando
    Cantu, Carlos
    Bousser, Marie-Germaine
    Stam, Jan
    STROKE, 2009, 40 (07) : 2356 - 2361
  • [43] Anticoagulation in cerebral venous sinus thrombosis
    Davie, C. A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 (07) : 933 - 934
  • [44] Anticoagulation for Cerebral Venous Sinus Thrombosis
    Coutinho, Jonathan M.
    de Bruijn, Sebastiaan F. T. M.
    deVeber, Gabrielle
    Stam, Jan
    STROKE, 2012, 43 (04) : E41 - E42
  • [45] Imaging of Cerebral Venous and Sinus Thrombosis
    Saadatnia, Mohammad
    GALEN MEDICAL JOURNAL, 2016, 5 : 43 - 47
  • [46] Cerebral sinus venous thrombosis in children
    Barnes, C
    Newall, F
    Furmedge, J
    Mackay, M
    Monagle, P
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2004, 40 (1-2) : 53 - 55
  • [47] Cerebral sinus-venous thrombosis
    Ida Martinelli
    Serena Maria Passamonti
    Elena Rossi
    Valerio De Stefano
    Internal and Emergency Medicine, 2012, 7 : 221 - 225
  • [48] Cerebral sinus-venous thrombosis
    Martinelli, Ida
    Passamonti, Serena Maria
    Rossi, Elena
    De Stefano, Valerio
    INTERNAL AND EMERGENCY MEDICINE, 2012, 7 : S221 - S225
  • [49] Cerebral venous sinus thrombosis in polycythaemia
    Thomson, D.
    Vyas, P.
    Hammersley, M. S.
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2008, 69 (03) : 170 - 170
  • [50] Epidemiology of cerebral venous sinus thrombosis and cerebral venous sinus thrombosis with thrombocytopenia in the United States, 2018 and 2019
    Payne, Amanda B.
    Adamski, Alys
    Abe, Karon
    Reyes, Nimia L.
    Richardson, Lisa C.
    Hooper, William Craig
    Schieve, Laura A.
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2022, 6 (02)